If finalised, the transaction will trigger a mandatory open offer for an additional 26 per cent stake from public shareholders

By Chitra Prakash

KKR is in final talks to acquire a 60.36 per cent stake in Healthcare Global Enterprises. (HCG), one of India's leading cancer care providers, as per Moneycontrol report. The deal, valued at Rs 4,663-4,935 crore at Rs 425-450 per share, which is currently in the negotiation phase, is centered around KKR's interest in gaining a majority share in the company, paving the way for potential expansion and enhanced capabilities within the healthcare sector.

If finalised, the transaction will trigger a mandatory open offer for an additional 26 per cent stake from public shareholders, potentially making KKR the majority owner. The deal could lead to HCG’s delisting if KKR's total stake surpasses 90 per cent. This move follows KKR’s recent return to the Indian healthcare sector after a gap of two years.

The acquisition aligns with KKR’s strategy to expand its healthcare investments in India. The deal, which could be finalised by January , marks a significant development in the private equity firm’s portfolio.